Skip to main content
Journal cover image

Cell-cycle phase progression analysis identifies three unique phenotypes in soft tissue sarcoma.

Publication ,  Journal Article
Cullen, MM; Lazarides, AL; Pittman, PD; Flamant, EM; Stoeber, KL; Stoeber, K; Visguass, JD; Brigman, BE; Riedel, RF; Cardona, DM; Somarelli, JA ...
Published in: BMC Cancer
October 17, 2024

PURPOSE: Loddo et al. (Br J Cancer 100:959-70, 2009) established the prognostic significance of cell cycle markers and "Cell-Cycle Phenotypes" in breast carcinoma. This study aims to 1) identify prognostic cell-cycle markers in sarcoma, and 2) assess the prognostic potential of specific cell-cycle phenotypes in sarcoma. METHODS: Tissue samples from 128 soft tissue sarcomas were stained for four cell cycle-specific markers: Mcm2, Geminin, Plk1, and H3S10ph. Only primary soft tissue tumors (liposarcoma, leiomyosarcoma, synovial sarcoma, and undifferentiated pleomorphic sarcoma) were included in the analysis. Any tumor coming from a recurrent or metastatic lesion were excluded from the analysis. Three cell-cycle phenotypes (I, II, III) were derived from marker expression patterns. Prognostic significance was evaluated in a subset of primary soft tissue sarcomas using Cox regression for survival analysis. RESULTS: Compared to phenotype I, the phenotype III tumors had a decreased 5-year overall survival (HR 6.81 [2.36-19.61]; p =  < 0.001), 5-year disease-free survival (HR 1.07 (1.02-1.18); p = 0.004), and 5-year metastasis-free survival (HR 4.34 [1.58-11.93]; p = 0.004). High expression of Plk1 was associated with decreased 5-year overall survival (HR: 4.04 CI [1.21-6.67; p = 0.02) and 5-year metastasis-free survival (HR: 2.91 CI [1.15-7.37]; p = 0.03). Geminin was also found to have a decreased 5-year overall survival (HR:2.84 CI [1.21-6.67]; p = 0.02). No statistical difference in prognostication were noted between phenotypes and the AJCC system. CONCLUSIONS: We identified three unique sarcoma cell cycle phenotypes that have prognostic significance. This performs similarly to the AJCC staging system.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

BMC Cancer

DOI

EISSN

1471-2407

Publication Date

October 17, 2024

Volume

24

Issue

1

Start / End Page

1288

Location

England

Related Subject Headings

  • Young Adult
  • Sarcoma
  • Prognosis
  • Polo-Like Kinase 1
  • Phenotype
  • Oncology & Carcinogenesis
  • Middle Aged
  • Male
  • Humans
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Cullen, M. M., Lazarides, A. L., Pittman, P. D., Flamant, E. M., Stoeber, K. L., Stoeber, K., … Eward, W. C. (2024). Cell-cycle phase progression analysis identifies three unique phenotypes in soft tissue sarcoma. BMC Cancer, 24(1), 1288. https://doi.org/10.1186/s12885-024-13043-6
Cullen, Mark M., Alexander L. Lazarides, Patricia D. Pittman, Etienne M. Flamant, Kathryn L. Stoeber, Kai Stoeber, Julia D. Visguass, et al. “Cell-cycle phase progression analysis identifies three unique phenotypes in soft tissue sarcoma.BMC Cancer 24, no. 1 (October 17, 2024): 1288. https://doi.org/10.1186/s12885-024-13043-6.
Cullen MM, Lazarides AL, Pittman PD, Flamant EM, Stoeber KL, Stoeber K, et al. Cell-cycle phase progression analysis identifies three unique phenotypes in soft tissue sarcoma. BMC Cancer. 2024 Oct 17;24(1):1288.
Cullen, Mark M., et al. “Cell-cycle phase progression analysis identifies three unique phenotypes in soft tissue sarcoma.BMC Cancer, vol. 24, no. 1, Oct. 2024, p. 1288. Pubmed, doi:10.1186/s12885-024-13043-6.
Cullen MM, Lazarides AL, Pittman PD, Flamant EM, Stoeber KL, Stoeber K, Visguass JD, Brigman BE, Riedel RF, Cardona DM, Somarelli JA, Eward WC. Cell-cycle phase progression analysis identifies three unique phenotypes in soft tissue sarcoma. BMC Cancer. 2024 Oct 17;24(1):1288.
Journal cover image

Published In

BMC Cancer

DOI

EISSN

1471-2407

Publication Date

October 17, 2024

Volume

24

Issue

1

Start / End Page

1288

Location

England

Related Subject Headings

  • Young Adult
  • Sarcoma
  • Prognosis
  • Polo-Like Kinase 1
  • Phenotype
  • Oncology & Carcinogenesis
  • Middle Aged
  • Male
  • Humans
  • Female